http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2252263-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca254cb6a2c92ef3429fd434c71a5d7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a153f0a1b53fa754774ff1f85464faa6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
filingDate 2009-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_748b8aa37c9c6851e494f2e62235d3e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03807056c34722ced3586d75bd43b28d
publicationDate 2010-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2252263-A1
titleOfInvention Galenic form for the oral transmucosal delivery of triptans
abstract The invention relates to a galenic form for the oral transmucosal delivery of at least one active ingredient of the family of triptans, comprising at least: said active ingredient in base form and in salt form, and an aqueous-alcoholic solution with a titer of at least 15 degrees alcohol, said active ingredient being present in a stable and complete dissolution state in the aqueous-alcoholic solution, for rapid absorption of said active ingredient through the mucosa of the oral cavity and/or of the oropharynx. The invention also relates to a method for obtaining this galenic formulation and to the use thereof.
priorityDate 2008-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226449465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129723338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127427940
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426654
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128419875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129386323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7618

Total number of triples: 41.